CLLS(CLLS)
CLLS
Q4 2026 EPS Estimate
$-0.20
Nov 13, 2026 · Reports after close
Revenue Estimate
$15M
Analyst Sentiment
Wall St. Consensus
Buy17 analysts·Moderate coverage
69
Score
14 Buy (82%)2 Hold (12%)1 Sell (6%)
Rating Breakdown
Strong Buy
00%
Buy
1482%
Hold
212%
Sell
16%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$9.00
+397.2%
Consensus
$9.00
+397.2%
Bull
$9.00
+397.2%
12-Month Target Range17 analysts
$9.00$9.00$9.00
Current $1.81Consensus
Current Price
$1.81
Upside to Consensus
$7.19
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+100.36%
EPS—
FY2028
Rev-57.50%
EPS—
FY2029
Rev+53.52%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $62M | $123M | $52M | $80M | $161M |
| Low | $39M | $41M | $24M | $37M | $74M |
| High | $86M | $199M | $80M | $122M | $245M |
| EBITDA Avg | $-55M | $-30M | $-97M | $-73M | $-24M |
| Low | $-90M | $-63M | $-183M | $-144M | $-67M |
| High | $-23M | $-7M | $-6M | $1M | $20M |
| EBIT Avg | $-76M | $-56M | $-121M | $-98M | $-56M |
| Low | $-110M | $-88M | $-207M | $-170M | $-99M |
| High | $-44M | $-33M | $-31M | $-24M | $-12M |
| Net Income Avg | $-83M | $-62M | $-128M | $-105M | $-63M |
| Low | $-117M | $-95M | $-214M | $-176M | $-106M |
| High | $-51M | $-40M | $-38M | $-31M | $-19M |
| EPS Avg | $-0.83 | $-0.62 | $-1.27 | $-1.05 | $-0.63 |
| Low | $-1.17 | $-0.95 | $-2.13 | $-1.76 | $-1.06 |
| High | $-0.50 | $-0.39 | $-0.38 | $-0.31 | $-0.19 |
| Analysts (Rev / EPS) | 5 / 6 | 5 / 5 | 1 / 2 | 2 / 1 | 2 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $15M | $21M | $26M | $35M | $73M | $96M |
| Low | $10M | $10M | $15M | $20M | $40M | $53M |
| High | $20M | $47M | $49M | $65M | $134M | $176M |
| EBITDA Avg | $-14M | $-15M | $-28M | $-24M | $908,063 | $2M |
| Low | $-17M | $-47M | $-66M | $-59M | $-7M | $-6M |
| High | $-9M | $17M | $-8M | $-6M | $5M | $7M |
| EBIT Avg | $-18M | $-20M | $-33M | $-30M | $-5M | $-6M |
| Low | $-21M | $-51M | $-71M | $-64M | $-14M | $-14M |
| High | $-13M | $12M | $-13M | $-11M | $-1M | $-1M |
| Net Income Avg | $-20M | $-22M | $-35M | $-32M | $-8M | $-8M |
| Low | $-23M | $-53M | $-73M | $-66M | $-16M | $-16M |
| High | $-15M | $8M | $-15M | $-13M | $-3M | $-3M |
| EPS Avg | $-0.20 | $-0.22 | $-0.35 | $-0.31 | $-0.07 | $-0.08 |
| Low | $-0.23 | $-0.53 | $-0.72 | $-0.66 | $-0.16 | $-0.16 |
| High | $-0.15 | $0.08 | $-0.15 | $-0.13 | $-0.03 | $-0.03 |
| Analysts (Rev / EPS) | 5 / 6 | 5 / 6 | 4 / 2 | 4 / 2 | 4 / 2 | 4 / 2 |
